Voya Investment Management LLC Akebia Therapeutics, Inc. Transaction History

Voya Investment Management LLC

  • $78.9 Billion
  • Q4 2024

A detailed history of Voya Investment Management LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 63,842 shares of AKBA stock, worth $134,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,842
Previous 70,361 9.27%
Holding current value
$134,068
Previous $92,000 28.26%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$1.26 - $2.13 $8,213 - $13,885
-6,519 Reduced 9.27%
63,842 $118,000
Q3 2024

Feb 07, 2025
SELL
$0.94 - $1.55 $1,255 - $2,070
-1,336 Reduced 1.86%
70,361 $92,000
Q3 2024

Nov 14, 2024
SELL
$0.94 - $1.55 $1,255 - $2,070
-1,336 Reduced 1.86%
70,361 $92,000
Q2 2024

Feb 07, 2025
BUY
$0.86 - $1.63 $1,148 - $2,177
1,336 Added 1.9%
71,697 $73,000
Q2 2024

Dec 03, 2024
BUY
$0.86 - $1.63 $1,148 - $2,177
1,336 Added 1.9%
71,697 $73,000
Q2 2024

Aug 14, 2024
BUY
$0.86 - $1.63 $61,659 - $116,866
71,697 New
71,697 $73,000
Q2 2022

Aug 15, 2022
BUY
$0.32 - $0.67 $56,499 - $118,295
176,561 Added 141.05%
301,740 $107,000
Q1 2022

May 16, 2022
BUY
$0.72 - $2.93 $18 - $76
26 Added 0.02%
125,179 $90,000
Q4 2021

Feb 14, 2022
BUY
$2.26 - $3.34 $22,202 - $32,812
9,824 Added 8.52%
125,153 $283,000
Q3 2021

Nov 15, 2021
BUY
$2.35 - $3.88 $20,562 - $33,950
8,750 Added 8.21%
115,329 $332,000
Q2 2021

Aug 16, 2021
SELL
$2.83 - $4.2 $7,793 - $11,566
-2,754 Reduced 2.52%
106,579 $403,000
Q1 2021

May 17, 2021
BUY
$2.92 - $5.06 $34,336 - $59,500
11,759 Added 12.05%
109,333 $370,000
Q4 2020

Feb 16, 2021
BUY
$2.22 - $3.78 $28,320 - $48,221
12,757 Added 15.04%
97,574 $273,000
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $94,364 - $516,437
39,483 Added 87.09%
84,817 $213,000
Q2 2020

Aug 14, 2020
SELL
$6.67 - $13.58 $87,883 - $178,930
-13,176 Reduced 22.52%
45,334 $616,000
Q1 2020

May 15, 2020
BUY
$4.1 - $10.24 $6,965 - $17,397
1,699 Added 2.99%
58,510 $444,000
Q4 2019

Feb 14, 2020
BUY
$3.16 - $6.73 $42,928 - $91,427
13,585 Added 31.43%
56,811 $359,000
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $31,840 - $62,516
7,766 Added 21.9%
43,226 $209,000
Q1 2019

May 15, 2019
SELL
$5.41 - $8.73 $10,636 - $17,163
-1,966 Reduced 5.25%
35,460 $290,000
Q4 2018

Feb 14, 2019
BUY
$5.39 - $9.15 $88,347 - $149,977
16,391 Added 77.92%
37,426 $207,000
Q2 2018

Aug 14, 2018
BUY
$9.15 - $11.34 $6,652 - $8,244
727 Added 3.58%
21,035 $210,000
Q3 2017

Nov 14, 2017
BUY
$13.06 - $19.67 $265,222 - $399,458
20,308
20,308 $399,000

Others Institutions Holding AKBA

# of Institutions
130
Shares Held
63.3M
Call Options Held
67.1K
Put Options Held
203K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $386M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email